Posted in | News | Optics and Photonics

Global Leader Selects Agilent's ADS Software to Support Development of Optics Products

Agilent Technologies Inc. today announced that Finisar, a global leader in fiber optic solutions for high-speed networks, has selected Agilent's Advanced Design System (ADS) software to support the development of their optics products designed for the telecom market. Agilent's ADS software platform includes the Signal Integrity Design Suite and the Ptolemy system simulator.

“As the technology leader in optical communication networks, we believe it is fundamental to have best-in-class software when creating leading-edge products for our customers,” said Kevin McCallion, director of engineering at Finisar. “We purposely chose Agilent's EDA software because of its impressive simulation technology and flexible design environment.”

“We are excited that Finisar has selected our ADS software platform for the design of their high-performance telecom optics products,” said Sanjeev Gupta, product marketing manager, Agilent's EEsof EDA division. “The signal integrity design and simulation capabilities within ADS provide a critical toolset that, we believe, will be a huge help in getting our customers' products to market more quickly.”

Agilent's ADS is an industry-leading high-frequency, high-speed electronic design automation software platform. Recent releases of the software include new signal integrity capabilities, such as the addition of serializer/deserializer(SERDES)/Verilog analog mixed-signal co-simulation, for a more complete signal integrity design flow for serial links.

Agilent's Ptolemy Simulator is a system-level simulator based on a hybrid of synchronous and timed synchronous dataflow technologies. It simplifies the design and simulation of digital (DSP), analog, and mixed-signal based RF systems and circuits, including wireless and wireline receivers, transmitters, modems, cellular phones, and radar.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.